Chronic severe ischemic ventricular dysfunction. Determinants of operative risk and long-term clinical outcome;Disfunción ventricular isquémica crónica severa. Determinantes del riesgo quirúrgico y del resultado clínico a largo plazo

Revista Espanola de Cardiologia

Volumn 50, Issue 12, 1997, Pages 870-881

  Silva Guisasola, Jacobo ^a   Gonzalez Santos, José Maria ^a,b   Ruiz Fernández, Manuel ^a   Castaño Ruiz, Mario ^a   López Rodríguez, Javier ^a   Bastida Centenera, Emilia ^a   Riesgo Benito, Mariano ^a   Salvador, José Albertos ^a   Vallejo Ruiz, José Luis ^a  

^a Hosp Gen Urniversitario G   (Spain)

^b EAP Santa Hortensia   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AGED; ARTICLE; COMPARATIVE STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HEART STROKE VOLUME; HEART VENTRICLE FUNCTION; HUMAN; MALE; MIDDLE AGED; MORTALITY; RISK FACTOR; STATISTICAL ANALYSIS; TIME; TREATMENT OUTCOME;

AGE FACTORS; AGED; CORONARY ARTERY BYPASS; CORONARY DISEASE; DATA INTERPRETATION, STATISTICAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION;

EID: 2542495138     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-8932(97)74694-3     Document Type: Article

References (30)

1. Louie HW, Laks H, Milgater E, Drinkwater DC Jr, Hamilton MD, Brunken RC et al. Ischemic cardiomyopathy. Criteria for coronary revascularization and heart transplantation. Circulation 1991;84(Supl 3):290-295.
2. Milano CA, White WD, Smith LR, Jones RH, Lowe JE, Smith PK et al. Coronary artery bypass in patients with severely depressed ventricular function. Ann Thorac Surg 1993; 53: 487-493.
3. Luciani GB, Faggian G, Razzolini R, Livi U, Bortolotti U, Mazzucco A. Severe ischemic left ventricular failure: coronary operation or heart transplantation? Ann Thorac Surg 1993; 55: 719-723.
4. The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. N Engl J Med 1984; 311: 1.333-1.339.
5. Passamani E, Davis KB, Gillespie MJ, Killip T. CASS principal investigators and associates. A randomized trial of coronary artery surgery bypass: survival of patients with a low ejection fraction. N Engl J Med 1985; 312: 1.665-1.671.
6. Burch GE, Giles TD, Colcolough HL. Ischemic cardiomyopathy. Am Heart J 1979; 79: 291-292.
7. Rahimtoola SH. The hibernating myocardium in ischemic and congestive heart failure. Eur Heart J 1993; 14 (Supl 1): 22-26.
8. Braunwald E, Kloner RA. The stunned myocardium: prolonged postischemic ventricular dysfunction. Circulation 1982; 66: 1.146-1.149.
9. Caralps JM, Martí V, Chávez J, Lapiedra O, Cámara ML, Padró JM et al. Resultados a largo plazo de la cirugía de bypass aortocoronario en pacientes con disfunción ventricular izquierda severa preoperatoria. Rev Esp Cardiol 1991; 44: 511-514.
10. Goor DA, Goran M, Bar-El Y, Modan M, Lucky A, Rozeman J et al. Synergism between infarct-borne left ventricular dysfunction and cardiomegaly in increasing the risk of coronary bypass surgery. J Thorac Cardiovasc Surg 1992; 104: 983-989.
11. Christakis GT, Weisel RD, Fremes SE, Ivanov J, David TE. Coronary artery bypass grafting in patients with poor ventricular function. J Thorac Cardiovasc Surg 1992; 103: 1.083-1.092.
12. Elefteriades JA, Tolis G, Levi E, Mills LK, Zaret BL. Coronary artery bypass grafting in severe left ventricular dysfunction: excellent survival and improved EF and functional state. J Am Coll Cardiol 1993; 32: 1.411-1.417.
13. Lansman SL, Cohen M, Galla JD, Machac J, Quintana CS, Ergin MA et al. Coronary bypass with ejection of 0.20 or less using centigrade cardioplegia: long-term follow-up. Ann Thorac Surg 1993; 56: 480-486.
14. Mickleborough LL, Maruyama H, Takagi Y, Mohamed S, Sun Z, Ebisuzaki L. Results of revascularization in patients with severe left ventricular dysfunction. Circulation 1995; 92 (Supl 2): 73-79.
15. Langenburg SE, Buchanan SA, Blackbourne LH, Sheri RP, Sinclair KN, Martinez J et al. Predicting survival after coronary revascularization for ischemic cardiomyopathy. Ann Thorac Surg 1995; 60: 1.193-1.197.
16. Kaul TK, Agnihotri AK, Fields BL, Riggins LS, Wyatt DA, Jones R. Coronary artery bypass grafting in patients with an ejection fraction of twenty percent of less. J Thorac Cardiovasc Surg 1996; 111: 1.001-1.012.
17. Kron IL, Flanagan TL, Blackboume LH, Schroeder RA, Nolon SP. Coronary revascularization rather than cardiac transplantation for chronic ischemic cardiomyopathy. Ann Surg 1989; 210: 348-354.
18. Dreyfus GD, Duboc D, Blasco A, Vigoni F, Dubois C, Brodaty D et al. Myocardial viability assessment in ischemic cardiomyopathy: benefits of coronary revascularization. Ann Thorac Surg 1994; 57: 1.402-1.408.
19. Magovern JA, Magovem GJ, Maher TD, Benckart DH, Park SB, Christlieb IY et al. Operation for congestive heart failure: transplantation, coronary artery bypass, and cardiomyoplasty. Ann Thorac Surg 1993; 56: 418-425.
20. Hausmann H, Wamecke H, Schiessler A, Ennker J, Hemple B, Topp H et al. Predictors of survival in patients with left ventricular ejection fraction of 10-30% receiving coronary artery bypass grafting: analysis of preoperative variables in 177 patients. Circulation 1991; 84 (Supl 2): 284.
21. Pfeffer MA, Branwuald E, Moyé LA, Basta L, Brown EJ Jr, Cudedy TE et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. N Engl J Med 1992; 327: 669-677.
22. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996, 334: 1.349-1.355.
23. Loop FD. Choice of conduits in coronary artery surgery. En: Glenn WWL, editor. Thoracic and cardiovascular surgery. Norwalk. Conn.: Appleton-Century-Crofts, 1983; 1.442-1.449.
24. Vanoverschelde JLJ, Gerber B, Pasquet A, Melin JA. Nuclear and echocardiographic imaging for prediction of reversible left ventricular ischemic dysfunction after coronary revasculanzation: current status and future directions. J Cardiovasc Pharmacol 1996; 28 (Supl 1): 27-26.
25. Di Carli MF, Asgarzadie F, Schelbert HR, Brunken RC, Laks H, Phelbs ME et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation 1995; 92: 3.436-3.444.
26. Kohli RS, DiSciascio G, Cowley MJ, Nath A, Goudreau E, Vetrovec G. Coronary angioplasty in patients with severe left ventricular dysfunction. J Am Coll Cardiol 1990; 16: 807-811.
27. Stevens T, Kahn JK, Mc Callister BD, Ligon RW, Spaude S, Rutherford BD et al. Safety and efficacy of percutaneous transluminal coronary angioplasty in patients with left ventricular dysfunction. Am J Cardiol 1991; 68: 313-319.
28. Serota H, Deligonul U, Lee WM, Aguirre F, Kern MJ, Taussig SA et al. Predictors of cardiac survival after percutaneous transluminal coronary angioplasty in patients with severe left ventricular dysfunction. Am J Cardiol 1991; 67: 367-372.
29. Holmes DR Jr, Detre KM, Williams DO, Kent KM, King SB III, Yeh W et al Long-term outcome of patients with depressed left ventricular function undergoing percutaneous transluminal coronary angioplasty. The NHLBI PTCA Registry. Circulation 1993; 87: 21-29.
30. Kron IL. When does one replace the heart in ischemic cardiomyopathy? Ann Thorac Surg 1993; 55: 581.